27 April 2025
: Case report 
From Erysipelas to Epiglottitis: Managing Complications in Invasive Group A Streptococcal Infection
Unusual clinical course
Shuhei Matsumoto ABCDEF 1, Takuya Masuda D 2, Nobuyoshi Minemura ABCDEF 2*, Hiroyoshi Nakajima DE 2, Keita Tatsuno
DE 3
DOI: 10.12659/AJCR.947291
Am J Case Rep 2025; 26:e947291
Table 1. Laboratory findings on admission.
| Normal limits | ||
|---|---|---|
| WBC | 8,500/µL | 3300–8600/µL |
| RBC | 467×10/µL | 386–492×10/µL |
| Hb | 14.0 g/dL | 11.6–14.8 g/dL |
| Ht | 42.1% | 35.1–44.4% |
| MCV | 90.1 fL | 83.6–98.2 fL |
| Plt | 14.3×10/µL | 15.8–34.8×10/µL |
| Alb | 4.2 g/dL | 6.6–8.1 g/dL |
| T-bil | 1.5 mg/dL | 0.4–1.5 mg/dL |
| D-bil | 0.4 mg/dL | 0–0.4 mg/dL |
| AST | 154 U/L | 13–30 U/L |
| ALT | 113 U/L | 7–23 U/L |
| AMY | 67 U/L | 44–132 U/L |
| LDH | 337 U/L | 124–222 U/L |
| γ-GT | 33 U/L | 9–32 U/L |
| BUN | 9 mg/dL | 8–20 mg/dL |
| Cr | 0.57 mg/dL | 0.46–0.79 mg/dL |
| CRP | 100.9 mg/L | 0.00–1.4 mg/L |
| Procalcitonin | 5.62 ng/mL | |
| PT | 11.0 sec | |
| APTT | 31.1 sec | 20–40 sec |
| Fibrinogen | 620 mg/dL | 150–300 mg/dL |
| TSH | 0.583 µIU/mL | 0.380–5.380 µIU/mL |
| Free T3 | 1.8 pg/mL | 1.7–3.7 pg/mL |
| Free T4 | 0.9 ng/dL | 0.7–1.5 ng/dL |